The PROOF Centre has biomarker programs to develop simple blood tests for a range of diseases, with core programs in cardiovascular disease, chronic obstructive pulmonary disease, and chronic kidney disease, and a multitude of collaborative projects in other disease areas, including muscular dystrophy, spinal cord injury, asthma and allergy, cystic fibrosis, vaccination, and diabetes.
Each biomarker program begins with understanding patients and clinical needs. Blood tests are tailored to maximize patient benefit while reducing healthcare costs. Working at the interface between data, technologies, human biology and end-users, the PROOF Centre brings research findings into real-world practical use.
An example of the process outlined above from our heart failure program is illustrated in the following infographic.